← SynDRA
RILZABRUTINIB
SynDRA canonical compound SYN0038412 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | BTK |
| Mechanism of action | Bruton's tyrosine kinase (BTK) inhibitor |
All known targets
Mechanisms of action (all sources)
- BTK INHIBITOR
- Tyrosine-protein kinase BTK inhibitor
- Bruton's tyrosine kinase (BTK) inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- WAYRILZ
- Wayrilz
- PRN-1008
- PRN1008
- (.ALPHA.E,3S)-
- (E)-PRN1008
- (E)-RILZABRUTINIB
- LCFFREMLXLZNHE-GBOLQPHISA-N
- SCHEMBL15506003
- BDBM143212
- US8940744, 31
- PRN 1008
- Rilzabrutinib [INN]
- Rilzabrutinib [USAN]
- NWN58M4F5T
- Example 31 [WO2014039899]
- Example 31 (WO2014039899)
- RefChem:883642
- Rilzabrutinib, (E)-
- 5G1WE425BI
- PRN1008, (E)-
- PRN-1008, (E)-
- Wayrilz (TN)
- UNII-NWN58M4F5T
- Rilzabrutinib [USAN:INN]
- Rilzabrutinib (PRN1008)
- UNII-5G1WE425BI
- GTPL9993
- orb1309216
- Rilzabrutinib (JAN/USAN/INN)
- SCHEMBL29368877
- SCHEMBL29564512
- C36H40FN9O3
- EX-A4524
- BDBM50557485
- EBC-64029
- EBC-84050
- NSC812901
- PRN 1008?
Look up RILZABRUTINIB in the interactive SynDRA portal →